Interleukin-10 inhibits the autocrine growth of leukemic blast cells from patients with acute myeloblastic leukemia

International Journal of Hematology

Volumn 66, Issue 4, 1997, Pages 445-450

  Asano, Yoshinobu ^a   Shibata, Shoichiro ^a   Kobayashi, Shinji ^a   Okamura, Seiichi ^a   Niho, Yoshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

AML; Autocrine growth; G CSF; GM CSF; IL 10

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 10;

ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOCRINE EFFECT; CANCER GROWTH; GROWTH INHIBITION; GROWTH REGULATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031422691     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(97)00070-4     Document Type: Article

References (16)

1. Fiorentino DF, Bond MW, Mosmann TR Two types of mouse helper T cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 170:1989;2081-2095.
2. Bogdan C, Vodovotz Y, Nathan C Macrophage deactivation by interleukin 10. J Exp Med. 174:1991;1549-1555.
3. 2 production by lipopolysaccharide-stimulated monocytes. Int Immunol. 6:1994;661-664.
4. + stem cells. Exp Hematol. 22:1994;136-141.
5. Geissler Ket al. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. J Exp Med. 184:1996;1377-1384.
6. Okamura Set al. Expression of cytokine genes in hematological malignancies. Acta Haematol Jpn. 52:1989;1423-1432.
7. Okamura S, Hayashi S, Asano Y, Shibuya T, Otsuka T, Niho Y Expression of the granulocyte/macrophage colony-stimulating factor gene in leukemic blast cells from patients with acute non-lymphocytic leukemia. Biomed Pharmacother. 42:1988;65-68.
8. Brach MAet al. Synergy of interleukin 3 and tumor necrosis factor-α in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor-α Cancer Res. 53:1992;2197-2201.
9. Asano Y, Shibuya T, Okamura S, Yamaga S, Otsuka T, Niho Y Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic blast cells. Cancer Res. 47:1987;5647-5648.
10. Asano Y, Shibuya T, Okamura S, Morioka E, Taniguchi S, Niho Y Synergism of leukemic blast growth factors in medium conditioned by human bladder carcinoma cell line 5637. Int J Cell Clon. 5:1987;504-510.
11. Asano Y, Okamura S, Shibuya T, Harada M, Niho Y Growth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factors. Blood. 72:1988;1682-1986.
12. Asano Yet al. Effect of human G-CSF on clonogenic cells in acute myeloblastic leukemia. Eur J Cancer Clin Oncol. 24:1988;1285-1287.
13. Niho Y, Till JE, McCulloch EA Granulopoietic progenitors in suspension culture: A comparison of stimulatory cells and conditioned media. Blood. 45:1975;811-821.
14. Hayashi Set al. Human bladder carcinoma cell line HTB9, which secretes a factor to stimulate clonogenic leukemic blast growth, expresses the granulocyte-macrophage colony-stimulating factor gene. Jpn J Cancer Res. 78:1987;1224-1258.
15. Lowenberg B, Touw IP Hematopoietic growth factors and their receptors in acute leukemia. Blood. 81:1993;281-292.
16. Chernoff AEet al. A randomized, controlled trial of IL-10 humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol. 154:1995;5492-5499.